Superficial bladder tumors and increased reactivity against mycobacterial antigens before bacillus Calmette-Guerin therapy

Journal of Urology

Volumn 159, Issue 6, 1998, Pages 1885-1891

  Zlotta, Alexandre R ^a   Drowart, Annie ^a   Van Vooren, Jean Paul ^a   Shekarsarai, Hossein ^a   De Cock, Michel ^a   Pirson, Michel ^a   Palfliet, Kamiel ^a   Jurion, Fabienne ^a   Simon, Jacques ^a   Schulman, Claude C ^a   Huygen, Kris ^a  

^a NONE

Author keywords

Antigens; BCG vaccine; Bladder neoplasms; Cross reactions

Indexed keywords

BCG VACCINE; MYCOBACTERIUM ANTIGEN; TUBERCULIN; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; FEMALE; HUMAN; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 0032412559     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63186-0     Document Type: Article

References (28)

1. Lamm, D. L.: Long-term results of intravesical therapy for superficial bladder cancer. Urol. Clin. N. Amer., 19: 573, 1992.
2. Morales, A., Eidinger, D. and Bruce, A. W.: Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J. Urol., 116: 180, 1976.
3. Böhle, A., Gerdes, J., Ulmer, A. J., Hofstetter, A. G. and Flad, H. D.: Effects of local bacillus Calmette-Guérin in patients with bladder carcinoma on immunocompetent cells of the bladder wall. J. Urol., 144: 53, 1990.
4. De Boer, E. C., De Jong, W. H., Steerenberg, P. A., Aarden, L. A., Tetteroo, E., De Groot, E. R., van der Meijden, A. P. M., Vegt, P. D. J., Debruyne, F. M. J. and Ruitenberg, E. J.: Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumor necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer. Cancer Immunol. Immunother., 34: 306, 1992.
5. Ratliff, T. L., Ritchey, J. K., Yuan, J. J., Andriole, G. L. and Catalona, W. J.: T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. J. Urol., 150: 1018, 1993.
6. Pryor, K., Goddard, J., Goldstein, D., Stricker, P., Russel, P., Golovsky, D. and Penny, R.: Bacillus Calmette-Guérin (BCG) enhances monocyte- and lymphocyte-mediated bladder tumor cell killing. Brit. J. Cancer., 71: 801, 1995.
7. Thanhauser, A., Böhle, A., Schneider, B., Reiling, N., Mattern, T., Ernst, M., Flad, H. D. and Ulmer, A. J.: The induction of bacillus Calmette-Guérin activated killer cells requires the presence of monocytes and T-helper type-1 cells. Cancer Immunol. Immunother., 40: 103, 1995.
8. Hayward, S., James, K., Prescott, S., Jackson, A. M., Ritchie, A. N. S., Smyth J. F. and Chisolm, G. D.: The effects of recombinant human interferon-gamma on a panel of human bladder cancer cell lines. J. Urol., 145: 1078, 1991.
9. Zlotta, A. R., Drowart, A., Van Vooren, J. P., De Cock, M., Pirson, M., Palfliet, K., Jurion, F., Vanonckelen, A., Simon, J., Schulman, C. C. and Huygen, K.: Evolution and clinical significance of the T-cell proliferative and cytokine response directed against the fibronectin-binding antigen 85 complex of bacillus Calmette-Guerin (BCG) during intravesical treatment of superficial bladder cancer. J. Urol., 157: 492, 1997.
10. Zlotta, A. R., Drowart, A., Huygen, K., De Bruyn, J., Shekarsarai, H., De Cock, M., Pirson, M., Jurion, F., Palfliet, K., Denis, O., Mascart, F., Simon, J., Schulman, C. C. and Van Vooren, J. P.: Humoral response against heat shock proteins and other mycobacterial antigens after intravesical treatment with bacillus Calmette-Guerin (BCG) in patients with superficial bladder cancer. Clin. Exp. Immunol., 109: 157, 1997.
11. Minden, P., McClatchy, J. K., Wainberg, M. and Weiss, D. W.: Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells. J. Natl. Cancer Inst., 53: 1325, 1974.
12. Bucana, C. and Hanna, M. G.: Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells. J. Natl. Cancer Inst., 53: 1313, 1974.
13. Huygen, K., Van Vooren, J. P., Turneer, M., Bosmans, R., Dierckx, P. and De Bruyn, J.: Specific lymphoproliferation, gamma interferon production and serum immunoglobulin G directed against a purified 32kD antigen (P32) in patients with active tuberculosis. Scand. J. Immunol., 27: 187, 1988.
14. Kaufmann, S. H. E.: Heat shock proteins and the immune response. Immunol. Today, 11: 129, 1990.
15. Dorken, E., Grzybowski, S. and Allen, E. A.: Significance of the tuberculin test in the elderly. Chest, 92: 237, 1987.
16. De Bruyn, J., Bosmans, R., Nyabenda, J. and Van Vooren, J. P.: Effect of zinc deficiency on the appearance of two immunodominant protein antigens (32 kDa and 65kDa) in culture filtrates of mycobacteria. J. Gener. Microbiol., 135: 79, 1989.
17. Multhoff, G., Botzler, C., Wiesnet, M., Muller, E., Meier, T., Wilmanns, W. and Issels, R. D.: A stress-inducible 72-kDa heat-shock protein (HSP72) is expressed on the surface of human tumor cells but not on normal cells. Int. J. Cancer, 61: 272, 1995.
18. Ferrarini, M., Heltai, S., Zocchi, M. R. and Rugarli, C.: Unusual expression and localization of heat-shock proteins in human cells. Int. J. Cancer, 51: 613, 1992.
19. Bruno, S., Machi, A. M., Semino, C., Meta, M., Ponte, M., Varaldo, M., Curotto, A., Ferlazzo, G., Decensi, A. and Melioli, G.: Phenotypic, functional and molecular analysis of lymphocytes associated with bladder cancer. Cancer Immunol. Immunother., 42: 47, 1996.
20. Lüftenegger, W., Ackerman, D. K., Futterlieb, A., Kraft, R., Minder, C. E., Nadelhalft, P. and Studer, U. E.: Intravesical versus intravesical plus intradermal bacillus Calmette-Guérin: a prospective randomized study in patients with superficial bladder tumors. J. Urol., 155: 483, 1996.
21. Wiker, H. G. and Harboe, M.: The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol. Rev., 56: 648, 1992.
22. Content, J., de la Cuvellerie, A., De Wit, L., Vincent-Levy-Frébault, V., Ooms, J. and De Bruyn, J.: The genes encoding for the antigen 85-complex of M. tuberculosis and M. bovis BCG are members of a gene family: cloning, sequence determination and genomic organization of the gene coding for the antigen 85-C. Infect. Immunol., 59: 3205, 1991.
23. Launois, P., Niang, M. B., De Bruyn, J., Sarthou, J. L., Rivier, F., Drowart, A., Van Vooren, J. P., Millan, J. and Huygen, K.: The major secreted antigen complex (AG 85) from M. bovis bacille Calmette-Guérin is associated with protective T-cells in leprosy; a follow-up study of 45 household contacts. J. Infect. Dis., 167: 1160, 1993.
24. Huygen, K., Content, J., Denis, O., Montgomery, D. L., Yawman, A. M., Deck, R. R., Dewitt, C. M., Orme, I. M., Baldwin, S., D'Souza, C., Drowart, A., Lozes, E., Vandenbussche, P., Van Vooren, J. P., Liu, M. A. and Ulmer, J. B.: Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med., 2: 893, 1996.
25. Kaver, I., Pecht, M., Trainin, N., Greenstein, A. and Braf, Z.: T lymphocyte substets and function in the peripheral blood of patients with urological cancer. Oncology, 49: 108, 1992.
26. Pansadoro, V., Emiliozzi, P., Donadio, D., Florio, A., Maurelli, S., Lauretti, S. and Sternberg, C. N.: Bacillus Calmette-Guérin in the treatment of stage T1 grade transitional cell carcinoma of the bladder: long-term results. J. Urol., 154: 2054, 1995.
27. Brown, S. T. and Almenoff, P. L.: Pulmonary mycobacterial infections associated with neoplasia. Sem. Respir. Infect., 7: 104, 1992.
28. Haasz, R. and Robinson, E.: Lymphocyte reactivity in healthy subjects and cancer patients. Acta Haematol., 3: 331, 1977.